Digital Health Accelerators Digital Health Today Ambassadors Digital Health Today Podcast Digital Health Today-Resources Digital Health Today Ambassadors

Digital Health Today 360°

Coffee Talk: How Innovative Companies can Partner with a Global Pharma Brand

Opportunities for joint ventures, late-stage investments and commercial partnerships at Bayer G4A
June 11, 2020
Coffee Talk: How Innovative Companies can Partner with a Global Pharma Brand
Advertisement

For this special Coffee Talk, I invited Sophie Park, Chief Strategist for Bayer G4A Partnerships to discuss the opportunities for innovative companies to grow and partner with a global pharma company.

The Bayer G4A program has continued to grow and succeed since 2013, and it has evolved to adapt to changing market forces, new business priorities and the unprecedented acceleration of innovation that has taken place at the intersection of health and technology. 

One of the challenges when an organization has a long history of success like that is that people begin to automatically associate what they knew about the program in previous years, and then overlay that to make presumptions about what the program is like this year.  For example – a lot of people think that G4A is simply an accelerator for early stage startups. In actual fact, they also have a very powerful partnership program which is designed to attract companies that can participate in joint ventures, commercial partnerships or even majority investments.  

In this episode, we dispel some of these myths and give more insights on the progress and success of the G4A program and family.

Learn more about Bayer G4A Partnership

Links and Resources:

Connect on Digital Health Today:

Browse Episodes | Twitter | Linkedin | Facebook | Instagram

Connect on Health Podcast Network:

Browse Shows | Linkedin | Twitter | Facebook | Instagram

 

Digital Health Today is made possible by the support of our sponsors. Thank you to

Learn more about your ad choices. Visit megaphone.fm/adchoices

cover
Coffee Talk: How Corporations Adapt in the Face of New Challenges Innovating at the speed of COVID-19. PLUS: Meet the new companies in the 2020 cohort of Bayer G4A
X
X